Concert Pharmaceuticals Overview

  • Founded
  • 2006
Founded
  • Status
  • Public
  • Employees
  • 70
Employees
  • Stock Symbol
  • CNCE
Stock Symbol
  • Share Price
  • $11.83
  • (As of Tuesday Closing)

Concert Pharmaceuticals General Information

Description

Concert Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company aims to discover and develop small-molecule drugs by incorporating new elements into known molecules or by leveraging the current approved drugs to be used for new treatments. The pipeline consists of small molecules designed for oral administration to cure cystic fibrosis, inflammation, narcolepsy, residual schizophrenia, major depressive disorder, and Alzheimer's agitation.

Contact Information

Website
www.concertpharma.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
NAS
Primary Office
  • 99 Hayden Avenue
  • Suite 3000N
  • Lexington, MA 02421
  • United States
+1 (781) 000-0000

Concert Pharmaceuticals Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Concert Pharmaceuticals Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$11.83 $11.71 $5.47 - $13.09 $351M 29.7M 127K -$2.69

Concert Pharmaceuticals Financials Summary

In Thousands,
USD 		TTM 30-Jun-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 149,028 109,376 116,427 382,015
Revenue 6,417 1,077 10,505 143,891
EBITDA (69,605) (76,502) (54,464) 97,162
Net Income (71,140) (78,166) (56,024) 95,639
Total Assets 171,999 137,471 192,547 211,736
Total Debt 16,377 16,264 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Concert Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Concert Pharmaceuticals‘s full profile, request access.

Request a free trial

Concert Pharmaceuticals Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion
Price		 % Owned

This information is available in the PitchBook Platform. To explore Concert Pharmaceuticals‘s full profile, request access.

Request a free trial

Concert Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Concert Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company aims to discover and develop smal
Biotechnology
Lexington, MA
70 As of 2019
00000
000000000 00000

00000000

enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo conse
0000000000000
South San Francisco, CA
00 As of 0000
00000
000000000 00000

00000

ctetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim a
0000000000000
Thousand Oaks, CA
00000 As of 0000
00.000
000000000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Concert Pharmaceuticals Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cortexyme Formerly VC-backed South San Francisco, CA 00 00000 000000000 00000
00000 Formerly PE-Backed Thousand Oaks, CA 00000 00.000 000000000000 00.000
0000000 Venture Capital-Backed Singapore, Singapore 00 00000 0000000000 0 00000
000000 00000000000 Formerly VC-backed San Diego, CA 000 00000 000000&0
000000 00000000 Formerly VC-backed Foster City, CA 00000 00.000 0&0
You’re viewing 5 of 14 competitors. Get the full list »

Concert Pharmaceuticals Executive Team (7)

Name Title Board Seat Contact Info
Roger Tung Ph.D Chief Executive Officer & Founder
Marc Becker Chief Financial Officer
Nancy Stuart Chief Operating Officer, Operations
Jeff Munsie JD Chief Legal Officer
James Cassella Ph.D Executive
You’re viewing 5 of 7 executive team members. Get the full list »

Concert Pharmaceuticals Board Members (13)

Name Representing Role Since
Christine van Heek Concert Pharmaceuticals Board Member 000 0000
Peter Hutt Self Board Member 000 0000
Richard Aldrich Self Chairman & Founder 000 0000
Ronald Barrett Ph.D Self Board Member 000 0000
Thomas Auchincloss Concert Pharmaceuticals Board Member 000 0000
You’re viewing 5 of 13 board members. Get the full list »

Concert Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Concert Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Concert Pharmaceuticals‘s full profile, request access.

Request a free trial